Shenzhen Mindray Bio-Medical Electronics Co Ltd: Financial Overview and Recent Developments
Shenzhen Mindray Bio-Medical Electronics Co Ltd, a prominent player in the healthcare equipment and supplies sector, operates primarily on the Shenzhen Stock Exchange. As of July 16, 2025, the company’s close price stood at 217.18 CNY, with a 52-week high of 351.6 CNY on October 7, 2024, and a 52-week low of 206.8 CNY on April 6, 2025. The company boasts a substantial market capitalization of 266,979,495,691 CNY and a price-to-earnings ratio of 24.3473.
Founded in 1991 and headquartered in Shenzhen, China, Mindray is a subsidiary of Mindray Medical International Limited. The company offers a comprehensive range of medical equipment and solutions, including patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories. Additionally, Mindray provides emergency care, peri-operative care, critical care, and IT solutions. Its product portfolio also includes in-vitro diagnostics products such as hematology and chemistry analyzers, chemiluminescence immunoassay products, flow cytometry products, hemoglobin systems, and micro plate readers and washers. Furthermore, the company offers medical imaging systems, including ultrasound and radiology products, as well as veterinary products.
Recent Market Movements and Related News
In recent financial news, the healthcare sector has seen various developments that could indirectly impact companies like Mindray. For instance, the AI fund Taikang HeRun Mixed A reported a second-quarter profit of 66.46 thousand yuan in 2025, with a net value growth rate of 0.76%. This fund, managed by Jiang Lijuan, is a bond-leaning mixed fund, reflecting broader market trends that could influence healthcare investments.
Additionally, the Shenzhen ETF (159903) has shown positive performance, opening with a 0.30% increase on July 18, 2025. Key holdings in this ETF include Ningde Times (up 1.21%) and Midea Group (up 0.33%), among others. The ETF’s performance is benchmarked against the Shenzhen Component Index, managed by Southern Asset Management.
In a notable development for the healthcare sector, Jiangsu Province People’s Hospital has introduced an “unattended care ward” with the assistance of AI technology from Meirui Medical. This initiative aims to address the challenges of medical care in an aging population by providing professional and personalized care services, potentially enhancing the demand for advanced medical equipment and solutions like those offered by Mindray.
Furthermore, the broader market has shown signs of improvement, with the Shanghai Composite Index rising by 3.26% in the second quarter of 2025. This positive trend in the equity market could bode well for healthcare companies, including Mindray, as investor confidence grows.
Overall, Shenzhen Mindray Bio-Medical Electronics Co Ltd remains a key player in the healthcare equipment and supplies industry, with a diverse product range and a strong market presence. The company’s performance will likely continue to be influenced by broader market trends and developments within the healthcare sector.